Cogent Biosciences (COGT) Net Cash Flow Growth (3y) (2020 - 2026)
Cogent Biosciences (COGT) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Cogent Biosciences |
5.09 Bn |
4.22 Bn |
- |
-75.46% |
| Date | Value |
|---|
| Mar 31, 2026 |
-75.46% |
| Dec 31, 2025 |
551.00% |
| Sep 30, 2025 |
78.02% |
| Jun 30, 2025 |
-77.20% |
| Mar 31, 2025 |
43.78% |
| Dec 31, 2024 |
-59.45% |
| Sep 30, 2024 |
37.15% |
| Jun 30, 2024 |
-116.85% |
| Mar 31, 2024 |
153.02% |
| Dec 31, 2023 |
-31.96% |
| Sep 30, 2023 |
-48.57% |
| Jun 30, 2023 |
102.78% |
| Mar 31, 2023 |
67.05% |
| Dec 31, 2022 |
56.80% |
| Sep 30, 2022 |
-164.64% |
| Jun 30, 2022 |
251.36% |
| Mar 31, 2022 |
-117.70% |
| Dec 31, 2021 |
38.12% |
| Sep 30, 2021 |
-100.44% |
| Jun 30, 2021 |
-37.42% |
